Yes, a "potential partneship" is a reality after a MANF incication gets orphan designation. But, will BP pay what Gerald is willing to take? That's the rub, same as with LymPro. I'm sure we could have gotten a JV Partner already if Gerald would have accepted their low ball offers.
I still maintain the strongest card we hold in our hand currently is Lympro revenue starting in January. It is the key to up listing and moving forward. One day MANF will surpass LymPro, but it is anyone's guess when.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links